A TGF-β1/LEF1/β-catenin/JLP network motif regulates autophagy and tubule injury in renal fibrosis
JCI Insight · 2026
DOI: 10.1172/jci.insight.196835 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Chen Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: beta Catenin, Autophagy, Transforming Growth Factor beta1, Lymphoid Enhancer-Binding Factor 1. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hubei Province Major Scientific and Technological Special Project.
Abstract (Originalsprache)
Sustained injury to renal tubular epithelial cells (TECs), driven by excessive autophagy, is a critical mechanism underlying kidney fibrosis. Our previous work identified JLP - a TEC-expressed scaffolding protein - as an endogenous antifibrotic factor that counteracts TGF-β1-induced autophagy and fibrogenesis. However, the mechanism underlying JLP downregulation in renal fibrosis remains unclear. Here, we delineated a TGF-β1/LEF1/β-catenin/JLP axis that governs TEC autophagy through a dichotomous regulatory circuit. Under physiological conditions, low levels of β-catenin and LEF1 with minimal nuclear localization permitted normal JLP expression, which in turn maintained autophagy in check. In contrast, during renal injury, TGF-β1 promoted the expression and nuclear translocation of β-catenin and LEF1, which together suppressed JLP transcription. This loss of JLP-mediated inhibition led to unchecked autophagy and exacerbated fibrotic damage. Analyses of kidney tissues from patients with CKD, murine fibrotic kidneys, and cultured HK-2 cells confirmed consistent JLP downregulation accompanied by upregulation and nuclear accumulation of LEF1 and β-catenin. Therapeutic intervention using the β-catenin/LEF1 inhibitor iCRT3 or LEF1-targeted silencing in murine fibrosis models restored JLP expression, attenuated TEC autophagy, and ameliorated renal fibrosis. These findings revealed an autoregulatory circuit controlling TEC autophagy and fibrogenesis, and supported LEF1 and β-catenin as potential therapeutic targets in CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China.
- Hubei Provincial Clinical Research Center for Kidney Disease, Wuhan, China.
- Department of Internal Medicine, and Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA.
Förderung
- National Natural Science Foundation of China
- Hubei Province Major Scientific and Technological Special Project
Zitieren
APA
Li, C., Zhang, M., Tian, M., Tang, Z., Hu, Y., Long, Y., Wang, X., Qiao, L., Zeng, J., Wang, Y., Chen, X., Chen, C., Li, X., Zhang, L., & Wang, H. (2026). A TGF-β1/LEF1/β-catenin/JLP network motif regulates autophagy and tubule injury in renal fibrosis. JCI Insight. https://doi.org/10.1172/jci.insight.196835
Vancouver
Li C, Zhang M, Tian M, Tang Z, Hu Y, Long Y, et al. A TGF-β1/LEF1/β-catenin/JLP network motif regulates autophagy and tubule injury in renal fibrosis. JCI Insight. 2026. doi:10.1172/jci.insight.196835
BibTeX
@article{Li2026,
author = {Li, Chen and Zhang, Meng and Tian, Maoqing and Tang, Zeyu and Hu, Yuying and Long, Yuyu and Wang, Xiaofei and Qiao, Liwen and Zeng, Jiefei and Wang, Yujuan and Chen, Xinghua and Chen, Cheng and Li, Xiaoyan and Zhang, Lu and Wang, Huiming},
title = {A TGF-β1/LEF1/β-catenin/JLP network motif regulates autophagy and tubule injury in renal fibrosis},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.196835}
}
EUVIMED